Viral vaccine and immunology lab at the Peter Doherty Institute, University of Melbourne. https://bsky.app/profile/viralvaxlab.bsky.socialhttps://bsky.app/profile/viralvaxlab.bsky.social/post/3lo3go4fros25We are excited to share our paper describing neutralising monoclonal antibodies against human coronavirus NL63, an alphacoronavirus that uses the same ACE2 receptor as SARS-CoV and SARS-CoV-2, but generally only causes mild respiratory illness. https://www.nature.com/articles/s44298-025-00116-x01 May 2025 04:06 +0000at://did:plc:yncm7fakh34kh3sg7igjgifi/app.bsky.feed.post/3lo3go4fros25https://bsky.app/profile/viralvaxlab.bsky.social/post/3lk3f7sjqf22l1/ Hot off the press in @jimmunol.bsky.social. We investigated how same side (ipsilateral) vs alternate side (contralateral) prime-boost vaccination impacts germinal center (GC) dynamics & antibody responses against SARS-CoV-2 spike in mice.💉🦠#immunology #vaccines @thedohertyinst.bsky.social11 Mar 2025 05:59 +0000at://did:plc:yncm7fakh34kh3sg7igjgifi/app.bsky.feed.post/3lk3f7sjqf22lhttps://bsky.app/profile/viralvaxlab.bsky.social/post/3lfdwjon3ps2xCheck out the latest from @skentskent.bsky.social and team - how does co-administration of influenza and COVID-19 vaccines affect immunity? Congrats to Wen Shi Lee, Kevin Selva and Jen Audsley on a great study and collaboration between the ViralVax and Chung labs! https://insight.jci.org/articles/view/187075 [contains quote post or other embedded content]10 Jan 2025 00:24 +0000at://did:plc:yncm7fakh34kh3sg7igjgifi/app.bsky.feed.post/3lfdwjon3ps2x